Acadia Healthcare Company, Inc. (NASDAQ:ACHC) saw a significant decline in short interest during the month of September. As of September 29th, there was short interest totalling 17,773,953 shares, a decline of 14.3% from the September 15th total of 20,744,872 shares. Currently, 21.0% of the shares of the company are sold short. Based on an average daily trading volume, of 654,559 shares, the short-interest ratio is presently 27.2 days.

ACHC has been the topic of a number of recent analyst reports. William Blair initiated coverage on Acadia Healthcare in a report on Tuesday, July 18th. They set an “outperform” rating on the stock. BidaskClub raised Acadia Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 1st. Mizuho lifted their price target on Acadia Healthcare from $57.00 to $60.00 and gave the company a “buy” rating in a report on Friday, July 28th. Deutsche Bank AG lifted their price target on Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a report on Monday, July 31st. Finally, Zacks Investment Research cut Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, October 2nd. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $57.40.

In other news, Director William Grieco sold 2,000 shares of Acadia Healthcare stock in a transaction that occurred on Friday, August 11th. The stock was sold at an average price of $51.71, for a total transaction of $103,420.00. Following the sale, the director now owns 45,013 shares of the company’s stock, valued at $2,327,622.23. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Reeve B. Waud sold 1,240,000 shares of Acadia Healthcare stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $51.72, for a total value of $64,132,800.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 3,085,693 shares of company stock worth $157,729,099. Corporate insiders own 11.10% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in ACHC. BlackRock Inc. lifted its holdings in Acadia Healthcare by 27,497.3% in the first quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock valued at $224,356,000 after buying an additional 5,127,140 shares during the period. Aristotle Capital Management LLC acquired a new position in Acadia Healthcare in the first quarter valued at approximately $140,071,000. William Blair Investment Management LLC lifted its holdings in Acadia Healthcare by 1,247.4% in the second quarter. William Blair Investment Management LLC now owns 2,128,972 shares of the company’s stock valued at $105,129,000 after buying an additional 1,970,965 shares during the period. Janus Henderson Group PLC acquired a new position in Acadia Healthcare in the second quarter valued at approximately $74,805,000. Finally, FMR LLC lifted its holdings in Acadia Healthcare by 173.2% in the first quarter. FMR LLC now owns 2,195,002 shares of the company’s stock valued at $95,702,000 after buying an additional 1,391,552 shares during the period.

Shares of Acadia Healthcare (ACHC) opened at 41.72 on Monday. Acadia Healthcare has a one year low of $32.54 and a one year high of $54.34. The company has a market cap of $3.67 billion, a PE ratio of 458.46 and a beta of 1.07. The company’s 50-day moving average price is $46.12 and its 200 day moving average price is $46.36.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The business had revenue of $715.90 million for the quarter, compared to analyst estimates of $717.38 million. During the same period in the prior year, the business posted $0.73 earnings per share. Acadia Healthcare’s revenue was down 5.4% compared to the same quarter last year. Equities analysts forecast that Acadia Healthcare will post $2.45 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Acadia Healthcare Company, Inc. (ACHC) Short Interest Down 14.3% in September” was first reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/10/15/acadia-healthcare-company-inc-achc-short-interest-down-14-3-in-september.html.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.